WALD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Waldencast PLC is not a strong buy at this moment for a beginner investor with a long-term focus. The technical indicators are neutral to slightly bearish, and there are no significant trading trends or proprietary trading signals supporting a buy. While the FDA approval for its product is a positive catalyst, the lack of financial data, valuation metrics, and analyst ratings makes it difficult to assess its long-term growth potential. Therefore, holding off on this investment is advisable.
The MACD is below 0 and negatively expanding, indicating bearish momentum. The RSI is neutral at 41.62, and moving averages are converging, showing no clear trend. The stock is trading below its pivot point of 1.761, with key support at 1.641 and resistance at 1.882.
FDA approval for Obagi saypha®ChIQ™ injectable hyaluronic acid gel, enhancing its position in the U.S. dermal filler market.
No significant trading trends from hedge funds or insiders. The stock has a 60% chance of declining by -6.84% in the next month based on historical candlestick patterns.
No financial data available for analysis.
No analyst ratings or price target changes available.
